AndroGel Buyer Seeks 2nd Shot At Pay-For-Delay Suit

By Brendan Pierson · March 8, 2010, 12:25 PM EST

An indirect purchaser of Solvay Pharmaceuticals Inc.'s testosterone supplement AndroGel has asked for leave to amend a recently dismissed putative class action accusing the drugmaker of keeping generics rivals out of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

IN RE: Androgel Antitrust Litigation (No. II)

Case Number

Court

Georgia Northern

Nature of Suit

Anti-Trust

Date Filed

October 05, 2009

Recent Articles By Brendan

August 11, 2010
J&J Faces Inquiries From State AGs Over Recalls
August 10, 2010
FTC May Have Spilled Watson's Secrets, CEO Says
August 06, 2010
St. Vincent's Moves To Sell Off 2 Nursing Homes
August 04, 2010
New Trial Ordered In $4M Wyeth Retaliation Suit
August 03, 2010
Eisai Calls For Tough Inequitable Conduct Standard
July 30, 2010
Sandoz Drops Generic Mirapex Plans For Now
July 20, 2010
AMA, Others Sue To Preserve Claims Against Wellpoint
July 19, 2010
5th Circ. Shoots Down Challenge To Vioxx Settlement
July 14, 2010
Ex-HealthSouth CEO Seeks Early Release From Prison
July 07, 2010
Skilled Healthcare Hit With $671M Verdict